National Cancer Registry

National Cancer Registry (NCR)

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09DA06	ATACAND PLUS	B	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg		Tablet	705,517 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 100mg	100mg	Injectable concentrated powder for solution	16,854,009 L.L
R06AX27	AERIUS	B	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	403,153 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
A16AB05	ALDURAZYME	B	Laronidase - 100U/ml	100U/ml	Injectable concentrate for solution	57,138,680 L.L
B05BA01	AMINOVEN INFANT	B	L-Leucine - 13g/l, L-Isoleucine - 8g/l, L-Lysine Acetate - 12g/l, L-Methionine - 3.12g/l, L-Phenylalanine - 3.75g/l, L-Threonine - 4.40g/l, L-Tryptophan - 2.01g/l, L-Valine - 9g/l, Arginine - 7.5g/l, L-Histidine - 4.76g/l, Glycine - 4.15g/l, L-Taurine - 0.40g/l, L-Serine - 7.67g/l, L-Alanine - 9.3g/l, L-Proline - 9.71g/l, N-Acetyl-L-Tyrosine - 5.176g/l, N-Acetyl-L-Cysteine - 0.70g/l, L-Malic Acid - 2.62g/l	10%	Injectable solution	880,217 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 60mg	60mg	Tablet, film coated	1,685,178 L.L
B05BA01	AMINOPLASMAL B. BRAUN	B	Amino acids - 10%	10%	Injectable solution	1,036,103 L.L
J02AA01	AMBISOME	B	Liposomal Amphotericin B - 50mg	50mg	Injectable powder for liposomal dispersion	13,126,040 L.L
A10BB12	AMARYL	B	Glimepiride - 1mg	1mg	Tablet	231,141 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 90mg	90mg	Tablet, film coated	2,119,240 L.L
A10BB12	AMARYL	B	Glimepiride - 2mg	2mg	Tablet	233,829 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 120mg	120mg	Tablet, film coated	603,385 L.L
C08CA01	AMLOR	B	Amlodipine besylate - 5mg	5mg	Capsule	560,382 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 1mg	1mg	Capsule, prolonged release	L.L
C08CA01	AMLOR	B	Amlodipine besylate - 5mg	5mg	Capsule	560,382 L.L
R03AL01	ATROVENT COMP. HFA	B	Fenoterol Hydrobromide - 20mcg/actuation, Ipratropium bromide - 50mcg/actuation		Inhalation aerosol metered dose	544,256 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 3mg	3mg	Capsule, prolonged release	L.L
A10BB12	AMARYL	B	Glimepiride - 3mg	3mg	Tablet	392,402 L.L
R03AL03	ANORO ELLIPTA	B	Vilanterol - 25mcg, Umeclidinium bromide - 62.5mcg		Inhalation powder	5,367,774 L.L
M02AA	AIRTAL DIFUCREM 1.5%	B	Aceclofenac - 1.5g/100g	1.5%	Cream	536,193 L.L
A10BB12	AMARYL	B	Glimepiride - 4mg	4mg	Tablet	392,402 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	L.L
R03BB01	ATROVENT	B	Ipratropium bromide - 250mcg/2ml	250mcg/2ml	Inhaltion solution with nebuliser	544,256 L.L
A10BD05	ACTOSMET	B	Metformin - 850mg, Pioglitazone - 15mg		Tablet, film coated	3,101,588 L.L
R03BB01	ATROVENT	B	Ipratropium bromide - 500mcg/2ml	500mcg/2ml	Inhaltion solution with nebuliser	713,580 L.L
M02AX10	ALGESAL SURACTIVE	B	Salycilic acid - 6.54g/100g, Diethylamine - 3.46g/100g, Myrtecaine - 1g/100g		Cream	1,006,538 L.L
R03BB01	ATROVENT N	B	Ipratropium bromide - 20mcg/actuation	20mcg/actuation	Inhalation aerosol metered dose	428,686 L.L
N06DA02	ARICEPT	B	Donepezil HCl - 5mg	5mg	Tablet, film coated	3,254,787 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L

...